BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioTelemetry (BEAT) Tops Q2 EPS by 19c
July 30, 2020 4:16 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.35, $0.19 better than the analyst estimate of $0.16. Revenue for the quarter came in at $99.1 million versus the consensus estimate of $89.52 million.
President and CEO Commentary
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:
Due to the unwavering commitment of the entire BioTelemetry team, we continued to successfully navigate the current external... More
